What is the current valuation of Beijing White Cat?

At present, the total share capital of Beijing Baipusisi is 80,000,000 shares, with 20,000,000 shares in circulation, which is issued by the whole network at the issue price of 1 12.5 yuan, with a market value of 2.25 billion yuan. The preliminary estimated market value is1.20-1.60 billion yuan, corresponding to the stock price 1.50-200 yuan. If the price is too high, we should pay attention to the risks.

Extended data

1. Introduction of PepsiCo

ACROBiosystems is a global brand focusing on protein's technology, products and services in biopharmaceutical research and development, and is committed to providing target antigens, other key reagents and related services needed in targeted therapeutic drug research and development. "More special product design, better and more stable quality, more perfect technical assistance, faster and more appropriate response" are the core values we hope to bring to our customers, so as to provide customers with simpler and faster drug research and development processes in the field of biopharmaceutical research and development.

The product catalogue of Beijing Baipusisi Biotechnology Co., Ltd. covers disease-related drug target antigens and biomarkers from humans to other common species. We are committed to providing high-quality protein products with high batch consistency and high-level molecular interaction services (SPR & amp； BLI) to meet strict standards in the field of drug research and development. Beijing Baipusaisi Biotechnology Co., Ltd. brings more value to customers with richer technical resources and customized services, provides more training and exchange opportunities in all aspects of biopharmaceuticals, and establishes platform cooperation for the whole world and every niche market.

2. What is the current valuation of 2.BPS?

This stock is the dragon in the domestic recombinant protein market, and Yi Long is Joey Shenzhou. Joey's domestic market share is 5%, and Peppa's is 4%, which is almost the same. Almost all the big heads are occupied by European and American manufacturers. The valuation of the first bridge height mainly depends on a piece of CRO service income, not Baipu. Although there is good growth in this aspect, the proportion of income in the whole is very low and almost negligible. It is essentially different from the company that specializes in CRO. Its main business is to make recombinant protein reagents like Baipu. Joey's share price has just reached 700, and the reasonable valuation of Babessez is at least 500-600.

3. What is the future development of 3.BPS?

PepsiCo has established a stable cooperative relationship with the top 20 pharmaceutical companies in the world, including Johnson & Johnson, Pfizer, Novartis and Merck, which produces therapeutic drugs for COVID-19. It is a truly international biomedical high-tech company. It can be seen that Perseus is growing very rapidly.